Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for the pediatric pembrolizumab study, with information about its design, participant eligibility, locations, and measures. It also includes study history, publications, and data-sharing details.SummaryDifference83%

- Check13 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision label updates from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record content. This resembles a permissions/server issue rather than a substantive update to the study data.SummaryDifference22%

- Check62 days agoChange DetectedThe UI now displays the label 'Find contact information' with a lower-case 'c' and shows a new 'Revision: v3.7.0' tag, replacing the previous 'Find Contact Information' and 'Revision: v3.6.6' text. These are cosmetic updates indicating a new page revision rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.